These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2681442)

  • 81. Clinical significance of anti-IFN-alpha antibody titres during interferon therapy.
    von Wussow P; Freund M; Block B; Diedrich H; Poliwoda H; Deicher H
    Lancet; 1987 Sep; 2(8559):635-6. PubMed ID: 2887929
    [No Abstract]   [Full Text] [Related]  

  • 82. Recombinant interferon-alpha 2 antibodies in chronic lymphocytic leukemia.
    McSweeney EN; Giles FJ; Goldstone AH
    J Interferon Res; 1994 Aug; 14(4):191-2. PubMed ID: 7822872
    [No Abstract]   [Full Text] [Related]  

  • 83. Antibodies to human leucocyte interferons in cancer patients.
    Trown PW; Kramer MJ; Dennin RA; Connell EV; Palleroni AV; Quesada J; Gutterman JU
    Lancet; 1983 Jan; 1(8316):81-4. PubMed ID: 6129455
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Kinetic aspects of membrane-based immunoaffinity chromatography.
    Nachman M
    J Chromatogr; 1992 Apr; 597(1-2):167-72. PubMed ID: 1517312
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Antibody to human leucocyte interferon may enhance the frequency of rhinovirus isolation.
    Phillpotts RJ
    Arch Virol; 1983; 75(1-2):143-5. PubMed ID: 6299242
    [No Abstract]   [Full Text] [Related]  

  • 86. Intron A--a therapeutic focus.
    Haworth C
    Br J Clin Pract; 1990 Nov; 44(11):471-4. PubMed ID: 2282299
    [No Abstract]   [Full Text] [Related]  

  • 87. Mutations of the human interferon alpha-2b gene in brain tumor patients exposed to different environmental conditions.
    Shahid S; Nawaz Chaudhry M; Mahmood N; Sheikh S
    Cancer Gene Ther; 2015 May; 22(5):246-61. PubMed ID: 25837663
    [TBL] [Abstract][Full Text] [Related]  

  • 88. In vitro interaction of interferon-alpha-2b with microspheres particles.
    Czejka MJ; Schüller J; Micksche M
    Pharmazie; 1992 May; 47(5):387. PubMed ID: 1409831
    [No Abstract]   [Full Text] [Related]  

  • 89. Antibodies to interferon alpha in patients.
    Antonelli G; Dianzani F
    Arch Virol Suppl; 1993; 8():271-7. PubMed ID: 8260872
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Molecular cloning, prokaryotic expression and its application potential evaluation of interferon (IFN)-ω of forest musk deer.
    Wu X; Yang W; Cheng JG; Luo Y; Fu WL; Zhou L; Wu J; Wang Y; Zhong ZJ; Yang ZX; Yao XP; Ren MS; Li YM; Liu J; Ding H; Chen JN
    Sci Rep; 2023 Jun; 13(1):10625. PubMed ID: 37391585
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Biological and clinical significance of neutralizing and binding antibodies to interferon-alpha (IFN-alpha) during therapy for chronic hepatitis C.
    Giannelli G; Antonelli G; Fera G; Del Vecchio S; Riva E; Broccia C; Schiraldi O; Dianzani F
    Clin Exp Immunol; 1994 Jul; 97(1):4-9. PubMed ID: 8033418
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Clinical toxicity of the interferons.
    Vial T; Descotes J
    Drug Saf; 1994 Feb; 10(2):115-50. PubMed ID: 7516663
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Development of neutralizing interferon antibodies after treatment with recombinant interferon-alpha 2b in patients with malignant carcinoid tumors.
    Oberg K; Alm GV
    J Interferon Res; 1989 Sep; 9 Suppl 1():S45-9. PubMed ID: 2809277
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Anti-interferon antibodies to interferon-alpha 2b: results of comparative assays and clinical perspective.
    Spiegel RJ; Jacobs SL; Treuhaft MW
    J Interferon Res; 1989 Sep; 9 Suppl 1():S17-24. PubMed ID: 2553829
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Incidence and clinical significance of neutralizing antibodies in patients receiving recombinant interferon-alpha 2a.
    Itri LM; Sherman MI; Palleroni AV; Evans LM; Tran LL; Campion M; Chizzonite R
    J Interferon Res; 1989 Sep; 9 Suppl 1():S9-15. PubMed ID: 2681444
    [TBL] [Abstract][Full Text] [Related]  

  • 96. [Anti-interferon antibody in chronic hepatitis C].
    Arai K; Shindo M; Okuno T
    Nihon Rinsho; 1994 Jul; 52(7):1929-34. PubMed ID: 7521441
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Low incidence of neutralizing antibody formation to interferon-alpha 2b in human recipients.
    Dianzani F; Antonelli G; Amicucci P; Cefaro A; Pintus C
    J Interferon Res; 1989 Sep; 9 Suppl 1():S33-6. PubMed ID: 2681442
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Humoral response to recombinant interferon-alpha 2b in patients receiving recombinant interferon-alpha 2b therapy.
    von Wussow P; Jakschies D; Freund M; Deicher H
    J Interferon Res; 1989 Sep; 9 Suppl 1():S25-31. PubMed ID: 2809276
    [TBL] [Abstract][Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.